According to a recent report, Johnson & Johnson, the world’s largest seller of health-care products, has discussed paying more than $3 billion to settle lawsuits over its recalled hip implants.
J&J’s Warsaw-based DePuy unit recalled 93,000 implants in 2010 – including 37,000 in the U.S. – after more than 12 percent failed within five years. That rate is climbing, along with suits by patients blaming the chromium and cobalt devices for pain, metal debris and replacement surgeries.
J&J seeks to resolve as many as 11,500 lawsuits in the U.S. and has considered paying more than $300,000 per case, according to the report. That kind of settlement would exceed $3 billion if most plaintiffs accept the terms, an amount 50 percent larger than proposed in previous discussions.
The company is pushing to resolve U.S. cases by early next year.
The report comes on the heels of a second revelation that medical device makers overall issued more than 400 recalls during the second quarter of this year. That is 30 percent more than in the previous quarter. That’s higher than reported for the last 5 quarter, according to a report by Stericycle ExpertRECALL.
The recalls affected about 9.2 million units, a 50 percent decrease in the quantity of products affected in Q1. Four recalls affected between 500,000 and 1 million units each, and no single recall affected more than 1 million products.